The Impact of the Social Factors and Rehabilitation Program to Address the Implications on Kidney Failure in Hail

May 8, 2023 updated by: Ahmed Abdelmoniem Ibrahim, University of Hail

The Impact of the Social Factors and Medical Rehabilitation Program to Address the Implications on Kidney Failure Disease in Hail Region (Under the Vision 2030)

The aims of our study to evaluate the effect of social factors and medical rehabilitation program on kidney function and quality of life among chronic kidney disease patients.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

  1. This study aims to evaluate the effect of social factors and medical rehabilitation program on kidney function and quality of life among chronic kidney disease patients.
  2. Identify the health problems facing patients with kidney failure in Hail region.
  3. Detect the reality of the problems facing patients with kidney failure in Hail region and ways to reduce them.
  4. Identify the family, psychological, economic and social problems facing patients with kidney failure in Hail region.

Study Type

Observational

Enrollment (Actual)

75

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 60 years (Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

participants with CKD stages (3 and 4) will be participated in this study, their ages ranged from 40 to 60 years. Both sexes will be included.

Participants should be: Saudi persons living in Hail City, married, both genders,

Description

Inclusion Criteria:

participants with CKD stages (3 and 4) will be participated in this study, their ages ranged from 40 to 60 years. Both sexes will be included.

Participants should be: Saudi persons living in Hail City, married, both genders,

Exclusion Criteria:

  • (1) Severe chronic cardiac problems. (2) Chronic chest disease. (3) Chronic inflammatory orthopedic disorders and rheumatoid arthritis. (4) Mental impairments.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
control

patients will take medical treatment only

patients will receive medical treatment in addition to aerobic exercises
Other: exercise
aerobic and resisted ex

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
6-minute walk test (6MWT). And Kidney Disease and Quality of Life (KDQOL™-36)
Time Frame: after 6 week
6-minute walk test (6MWT). And Kidney Disease and Quality of Life (KDQOL™-36)
after 6 week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
muscle power of lower limb
Time Frame: after 6 week
functional muscle test
after 6 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Hail

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 5, 2022

Primary Completion (Actual)

December 2, 2022

Study Completion (Actual)

December 5, 2022

Study Registration Dates

First Submitted

May 16, 2022

First Submitted That Met QC Criteria

May 16, 2022

First Posted (Actual)

May 20, 2022

Study Record Updates

Last Update Posted (Actual)

May 10, 2023

Last Update Submitted That Met QC Criteria

May 8, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • RG-191348

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe